Remanufacturing Guidance Adds Info On Premarket Requirements For Remanufacturers

Clarification needed on software

After clarifying what a remanufactured device is in its 2021 draft guidance, FDA’s final guidance adds information about regulatory requirements for companies whose devices qualify as remanufactured.

• Source: Shutterstock

The US Food and Drug Administration’s final guidance on remanufacturing devices now includes regulatory requirements and considerations for devices that are considered remanufactured.

The final guidance, Remanufacturing of Medical Devices, was published on 10 May and replaces the June 2021 document

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Guidance

More from Compliance